Key Metrics
CiteScore 

12.2
Impact Factor 

20 - 25
Scite Index 

0.94 5-Year SI

SJR 

Q4Oncology

SNIP 

2.84
Recommended pre-submission checks
Powered by 

Topics Covered on Nature Cancer
Nature Cancer Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Nature Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Nature Cancer
Author Correction: Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis.
- 22 Oct 2026
- Nature cancer
Author Correction: Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.
- 19 Oct 2026
- Nature cancer
Stroke-induced astrocyte memories promote glioma progression.
- 14 Oct 2026
- Nature cancer
Reframing cancer therapy through tumor plasticity.
- 14 Oct 2026
- Nature cancer
Author Correction: A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance.
- 12 Oct 2026
- Nature cancer
Author Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.
- 9 Oct 2026
- Nature cancer
Author Correction: Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis.
- 22 Oct 2026
- Nature cancer
Author Correction: Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.
- 19 Oct 2026
- Nature cancer
Stroke-induced astrocyte memories promote glioma progression.
- 14 Oct 2026
- Nature cancer
Reframing cancer therapy through tumor plasticity.
- 14 Oct 2026
- Nature cancer
Author Correction: A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance.
- 12 Oct 2026
- Nature cancer
Author Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.
- 9 Oct 2026
- Nature cancer